Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (11), 1410-21

The Effects of Moderate-Dose Steroid Therapy in Sepsis: A Placebo-Controlled, Randomized Study


The Effects of Moderate-Dose Steroid Therapy in Sepsis: A Placebo-Controlled, Randomized Study

Orhan Yildiz et al. J Res Med Sci.


Background: Despite the new developments in sepsis treatment, mortality rate is still high. In this study, we aimed to investigate endocrinologic changes and the effects of moderate dosage steroid treatment in patients with sepsis.

Methods: Fifty-five patients were included in the study. Basal hormonal evaluation and adrenocorticotropin hormone (ACTH) stimulation test were performed within 24 h in all patients. Both groups received standard treatment for sepsis. However, one group (steroid group) was also given intravenous prednisolone (20 mg/day). All-cause mortality was assessed during the first 28 days.

Results: Analysis of the findings revealed a 59.3% mortality rate in steroid group compared with a 53.6% mortality rate in placebo group (p = 0.787). Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores, and peak cortisol and ACTH levels were significant factors related to mortality. The incidence of adrenal insufficiency (AI) was 10.9% and relative adrenal insufficiency (RAI) 36.4%. It was also found that steroid treatment did not have any effects on the mortality of patients with AI and RAI (p = 0.075 and p = 0.999, respectively).

Conclusions: Moderate-dose steroid therapy has no effect on mortality. Higher basal cortisol and peak cortisol levels were found more reliable mortality indicators compared to RAI. In addition, the study revealed that ACTH level was a significant indicator of mortality.

Keywords: ACTH; Adrenal Insufficiency; Cortisol; Prednisolone; Sepsis.

Conflict of interest statement

Conflict of Interests Authors have no conflict of interests.


Figure 1
Figure 1
ROC curve analysis of basal cortisol for predicting survival from sepsis (The area under the ROC curve is 0.707)
Figure 2
Figure 2
Mortality rates according to basal cortisol categories (Panel A) and adrenal functional status (Panel B) in both groups

Similar articles

See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles


    1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 Suppl):S109–S116. - PubMed
    1. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365(9453):63–78. - PubMed
    1. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727–34. - PubMed
    1. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, et al. Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med. 2007;35(4):1012–8. - PubMed
    1. Zaloga GP. Sepsis-induced adrenal deficiency syndrome. Crit Care Med. 2001;29(3):688–90. - PubMed

LinkOut - more resources